Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 6
Submit an article Journal homepage
239
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia

Seiichiro KatagiriDepartment of Hematology, Tokyo Medical University, Tokyo, Japan; Correspondence[email protected]
,
Tomohiro UmezuDepartment of Hematology, Tokyo Medical University, Tokyo, Japan; ;Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan;
,
Kenko AzumaDepartment of Molecular Oncology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan;
,
Michiyo AsanoDepartment of Hematology, Tokyo Medical University, Tokyo, Japan;
,
Daigo AkahaneDepartment of Hematology, Tokyo Medical University, Tokyo, Japan;
,
Hideki MakishimaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;
,
Kenichi YoshidaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;
,
Yosaku WatataniDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;
,
Kenichi ChibaLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
,
Satoru MiyanoLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
,
Seishi OgawaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;
,
Junko H. OhyashikiDepartment of Molecular Oncology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan;
&
Kazuma OhyashikiDepartment of Hematology, Tokyo Medical University, Tokyo, Japan;
show all
Pages 1490-1493 | Received 17 Jun 2017, Accepted 16 Sep 2017, Published online: 03 Oct 2017

References

  • Schlenk RF, Döhner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1909–1918.
  • Medeiros BC, Minden MD, Schuh AC, et al. Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years). Leuk Lymphoma. 2007;48:65–71.
  • Czerw T, Labopin M, Gorin NC, et al. Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer. 2016;122:1880–1887.
  • Watts JM, Wang XV, Swords RT, et al. Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary. Bone Marrow Transplant. 2016;51:1013–1015.
  • Welch JS, Ley TJ, Link DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150:264–278.
  • Ding L, Ley TJ, Larson DE, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481:506–510.
  • Kindler T, Lipka DB, Fischer T. FLT3 as a therapeutic target in AML: still challenging after all these years. Blood. 2010;116:5089–5102.
  • Tiesmeier J, Müller-Tidow C, Westermann A, et al. Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy. Leuk Res. 2004;28:1069–1074.
  • Warren M, Luthra R, Yin CC, et al. Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients. Mod Pathol. 2012;25:1405–1412.
  • Meloni G, Mancini M, Gianfelici V, et al. Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability. Haematologica. 2009;94:298–300.
  • Baker SD, Zimmerman EI, Wang YD, et al. Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia. Clin Cancer Res. 2013;19:5758–5768.
  • Makishima H, Yoshizato T, Yoshida K, et al. Dynamics of clonal evolution in myelodysplastic syndromes. Nat Genet. 2017;49:204–212.
  • Pasqualucci L, Dominguez-Sola D, Chiarenza A, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011;471:189–195.
  • Beekman R, Valkhof MG, Sanders MA, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood. 2012;119:5071–5077.
  • Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126:9–16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.